Clinical Trials Logo

Excessive Daytime Sleepiness clinical trials

View clinical trials related to Excessive Daytime Sleepiness.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05458128 Active, not recruiting - Clinical trials for Idiopathic Hypersomnia

A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia

Start date: August 19, 2022
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to assess the long-term safety and effectiveness of pitolisant in patients with idiopathic hypersomnia (IH) who completed the Double-Blind Randomized Withdrawal Phase of study HBS-101-CL-010.

NCT ID: NCT04886518 Active, not recruiting - Clinical trials for Myotonic Dystrophy 1

Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1

Start date: June 28, 2021
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to evaluate the safety and efficacy of pitolisant compared with placebo in treating excessive daytime sleepiness (EDS) in patients with Myotonic Dystrophy Type 1 ages 18 to 65 years. The secondary objectives of this study are to assess the impact of pitolisant on fatigue, cognitive function and the burden of disease along with assessing the long-term safety and effectiveness of pitolisant in patients with Myotonic Dystrophy Type 1 ages 18 to 65 years.